Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Research
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Policy, Research
Obesity Treatment EASO Grade-Based Framework for the Pharmacological Treatment of Obesity and its Complications Barbara McGowan Department of Endocrinology and Diabetes, Guy’s and St Thomas’ Hospital NHS Trust, United Kingdom Watch now
Obesity Treatment A New Approach to Obesity Diagnosis, Staging, and Management Prof. Luca Busetto Department of Medicine, University of Padua, Italy Watch now
